Results 121 to 130 of about 8,213 (208)

Role of Stemloop D in Terminally Deleted Coxsackievirus B3 Replication

, 2016
Coxsackievirus B3 (CVB3) is an enterovirus with no known form of latency. However, assays designed to detect enteroviral RNA have shown that CVB3 RNA can persist for weeks beyond the acute infection both naturally and experimentally.
Jaramillo, Lee K.
core  

In vitro Production and Characterization of a Recombinant Viral Protein (rVP1) of Coxsackievirus B3 (CVB3): Contribution for the Development of a Subunit Vaccine or an Immunodiagnostic Reagent

Coxsackievirus B3 is an Enterovirus implicated in diverse human pathologies, from viral myocarditis to neurological disorders. There isn’t a medicinal agent or vaccine for CVB3 in clinical use at the moment, despite the possibility that vaccination could
Ameera Alyami, Ikbel Hadj Hassine, Manel Ben M’hadheb, Jawhar Gharbi   +3 more
core   +1 more source

Serologic prevalence of coxsackievirus group B in Greece

, 2007
Coxsackieviruses are human enteroviruses, which have been associated with myocarditis/pericarditis and sudden death. In one investigation (Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, and Legakis NJ: J Clin Pathol 2005;58:
Foundouli, K., Routsias, J. G., Levidiotou, S., Tsakris, A., Spanakis, N., Alexiou, S., Hatzitaki, M., Politi, C., Legakis, N. J., Mavrouli, M. D., Tseliou, P.   +10 more
core   +1 more source

3C suppresses PINK1-mediated mitophagy and contributes to coxsackievirus B3 replication. [PDF]

Virulence
Liu T, Wan A, Xu Y, Lu H, Xie Y, Wu H, Wang J, Wang H, Hao T, Zhang Y, Xu J, Shen H, Li S.   +12 more
europepmc   +1 more source

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication. [PDF]

Int J Mol Sci
Yuan L, Lin L, Bi C, Niu X, Chen Y, Fei Y, Wang G, Wang H, Wang Y, Zhao W, Zhong Z, Lin L.   +11 more
europepmc   +1 more source

Investigating the Potential Role of Capsaicin in Facilitating the Spread of Coxsackievirus B3 via Extracellular Vesicles. [PDF]

Int J Mol Sci
Chatterjee S, Kordbacheh R, Tilley H, Briordy D, Waldron RT, Cutts WD, Aleman J, Cook A, Dhanji R, Wong LR, Pandol SJ, Kim BJ, Fairweather D, Sin J.   +13 more
europepmc   +1 more source

Desmin mutations in cardiomyocytes increase susceptibility to coxsackievirus B3 infection by impairing antiviral IFN-β response and upregulating viral receptors expression. [PDF]

Stem Cell Res Ther
Callon D, Hovhannisyan Y, Friob G, Vartanian-Grimaldi JS, Guennec BE, Lebreil AL, Li Z, Suspène R, Andreoletti L, Fornès P, Berri F, Vartanian JP, Joanne P, Agbulut O.   +13 more
europepmc   +1 more source

The neddylation of the RNA-dependent RNA polymerase 3D of Coxsackievirus B3 promotes viral replication. [PDF]

J Virol
Li S, Dong Y, Wang X, Feng D, Luan T, Wang Z, Lin L, Chen Y, Wang Y, Fei Y, Wang Y, Zhong Z, Zhao W.   +12 more
europepmc   +1 more source

The Recombinant Viral Capsid Protein rVP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mouse Model. [PDF]

Vaccines (Basel)
Ben M'hadheb M, Hassine IH, Almalki MA, Hassine M, Gharbi J.   +4 more
europepmc   +1 more source

Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice. [PDF]

Viruses
Elsner L, Hinze L, Hazini A, Heimann L, Geisler A, Dieringer B, Klingel K, Linthout SV, Kurreck J, Klopfleisch R, Fechner H.   +10 more
europepmc   +1 more source